Nyse jnj compare.
The S&P 500 Index ( ^GSPC -0.20%) hit record highs (again) earlier this week, and is up to the tune of 45% over the past 12 months. By contrast, shares of Johnson & Johnson ( JNJ 0.81%) are only ...
While both Johnson & Johnson (NYSE:JNJ) and Medtronic (NYSE:MDT) are good companies, ... Hard to compare with JNJ, because MDT is med tech and JNJ is med tech + pharma + consumer goods.Dec 1, 2023 · On Friday, Johnson & Johnson (JNJ:NYQ) closed at 158.38, 9.27% above its 52-week low of 144.95, set on Oct 27, 2023. Data delayed at least 15 minutes, as of Dec 01 2023 21:10 GMT. Latest Johnson & Johnson (JNJ:NYQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Analysts expect JNJ’s revenue to increase 2.8% year-over-year to $97.62 billion for the fiscal year ending December 2023. The company’s EPS for the ongoing year is expected to rise 3.6% from the previous year to $10.51. Moreover, JNJ surpassed its consensus EPS estimates in all four trailing quarters, which is impressive.Johnson & Johnson has a Moderate Buy consensus rating based on four Buys, 10 Holds, and zero Sell ratings assigned over the last three months. At $179, the average Johnson & Johnson stock price ...Dec 23, 2020 · Merck’s margins have improved with the Trump tax cuts to pass Johnson & Johnson by a rate of 24% vs. 21% of sales. The balance sheets in summation look like mirror images at first glance. Below ...
Johnson & Johnson (NYSE:JNJ) stock price is marginally up 0.5% as it finalized the exchange ratio for the split-off of Kenvue. For each share of Johnson & Johnson common stock, it will deliver 8. ...NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for ...
Comparison Analysis Based on SEC Data. Company Name. Johnson & Johnson. Industry (SIC) 2834 - Pharmaceutical Preparations. Revenue in 2022. $94,943 million (ranked #2 out of 645 companies in the industry) Assets as of 12/31/2022. $187,378 million (ranked #2)
We believe that Pfizer stock (NYSE: PFE) is currently a better pick than its peer, Johnson & Johnson stock (NYSE: JNJ), given its relatively lower valuation of 3.1x trailing revenues, compared to ...... Compare All. STREET NATION. ETF Focus · Retirement Daily · Apple Maven · Boardroom Alpha ... 157.22688. Ask. 158.50. Ask Size. 300. Exchange. NYSE. Dividend. 1.19 ...Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Johnson & Johnson (JNJ) NYSE - NYSE Delayed Price. Currency in USD Follow 2W 10W 9M 158.38 +3.72 (+2.41%) At close: 04:00PM EST We believe that pharmaceutical giants Johnson & Johnson stock (NYSE: JNJ) and Merck stock (NYSE: MRK) will likely offer similar returns over the next three years. Both companies are trading at a ...
The Street’s Moderate Buy consensus rating on Johnson & Johnson stock is based on four Buys and seven Holds. At $181.60, the average JNJ stock price prediction suggests 5% upside potential.
Johnson & Johnson ( NYSE: JNJ) is finally parachuting away from the "plane crash" of talc-related litigations originally worth over $4B. In addition to the $5B opioid settlement, the company ...
Johnson & Johnson (NYSE: JNJ) Third place goes to Johnson & Johnson (NYSE: JNJ), a pharmaceutical giant whose share price declined by 11% in the past twelve months, significantly underperforming the market return of 14%. However, the stock has shown a positive trend, rising by 6.3% over the past three years.Real-time Price Updates for Johnson & Johnson (JNJ-N), along with buy or ... Instrument Name Johnson & Johnson Instrument Symbol (JNJ-N). Instrument Exchange NYSE.$JNJ - almost time to enterLooking at the chart dating back 5 years for NYSE:JNJ , there is a decent entry point around $150. Looking for a slight drop in ...Thus, pharma companies JNJ and MDGL are well-positioned to benefit from the industry’s tailwinds. JNJ has declined 1.5% over the past three months, while MDGL plunged 37.2%. JNJ has slumped 10.7% over the past nine months, compared to MDGL’s 52.3% decline. However, JNJ fell 4% over the past year, while MDGL gained 97.4%.May 9, 2023 · ABBV has an FY1 P/E ratio of 13.49x, compared to JNJ’s 15.27x. As a result, ABBV's PEG ratio turns out to be 1.55x and JNJ's 2.57x, both higher than the preferred threshold of 1x that Lynch ...
Medtronic (NYSE: MDT) recently reported its Q2 fiscal 2024 results (fiscal ends in April), with revenues and earnings beating our estimates, and we believe that MDT st ... Results from Johnson & Johnson NYSE: JNJ and Abbott Laboratories NYSE: ABT foreshadow good news for MedTech investors. Both companies outperformed on the top …Johnson & Johnson's dividend of currently $1.19 per share and quarter represents an annualized dividend yield of 2.95%, which is quite attractive by historical standards. Taking into account the ...View our stock quotes and sample our research offering. Explore Our Research Tools. Try our powerful stock tools to help compare investments and get ideas.The asset acquisition will require an in-process R&D charge, which will reduce Johnson & Johnson's ( NYSE: JNJ) operational and reported adjusted EPS for fiscal year 2023 by ~$0.17 from guidance ...Kenvue went public at $22 per share, as the 173 million shares sold by Johnson grant it $3.8 billion in gross proceeds. The company holds about 1.72 billion shares in the company after the IPO and ...The PE ratio of Johnson & Johnson has averaged 45.3 over the last ten years. The current P/E ratio of 11.12 is 75% lower than the historical average. Looking back at the last ten years, JNJ's PE ratio peaked in the Dec 2017 quarter at 291.08, when the price was $139.72 and the EPS was $0.48. The lowest point was in the Oct 2023 quarter, when it ...
It grew by an impressive 22% year over year to $986 million in the most recent reported first quarter. Total revenue for the quarter rose by 14% to $1.7 billion from the year-ago period. Since the ...
74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Johnson & Johnson (JNJ) NYSE - NYSE Delayed Price. Currency in USD Follow 2W 10W 9M 158.38 +3.72 (+2.41%) At close: 04:00PM EST Johnson & Johnson (JNJ) key stats comparison: compare with other stocks by ... NYSE | $USD | Realtime. Summary · Ratings · Financials · Earnings · Dividends ...Johnson & Johnson (JNJ). NYSE. Symbol. Exchange. Currency. JNJ, NYSE, USD, Real-time ... compared to the 3.7% reading seen in August. Overall, while the trend is.That same $10,000 investment compounded at 14.56% for 30 years would yield $590,187.69, a nearly 587% increase. Yet, when we look at the return of Johnson & Johnson (NYSE: NYSE: JNJ) vs the S&P ...It grew by an impressive 22% year over year to $986 million in the most recent reported first quarter. Total revenue for the quarter rose by 14% to $1.7 billion from the year-ago period. Since the ...AbbVie ( ABBV 0.14%) and Johnson & Johnson ( JNJ 1.11%) did something many other stocks didn't last year. They outperformed the S&P 500 index. These pharmaceutical giants defied the bear market as ...Overview Key Ratios Peer Comparison Financials Share Holdings Other details Johnson & Johnson (JNJ) Share Price NYSE $151.28 As on 27-Nov-2023 16:10 …Johnson & Johnson (JNJ) key stats comparison: compare with other stocks by ... NYSE | $USD | Realtime. Summary · Ratings · Financials · Earnings · Dividends ...
Johnson & Johnson reported a 34% decline in Medical Devices sales in Q2 2020. Notably, Merck’s P/E is lower than the levels seen in 2018 and 2019. On the other hand, Johnson & Johnson’s P/E ...
The JNJ stock has also demonstrated a good track record of adequately handling downside deviation or harmful volatility, and this reflects well on the expected Sortino ratio (a reading above 1.0 ...
Johnson & Johnson announced its 61st consecutive dividend increase and it raised its 2023 outlook along with beating top and bottom line estimates. Find out why JNJ stock is a Buy.Nov 30, 2023 · J&J stock price quote (NYSE: JNJ), historical charts, related news, stock analyst insights and more to help you make the right investing decisions. Real-time Price Updates for Johnson & Johnson (JNJ-N), along with buy or ... Instrument Name Johnson & Johnson Instrument Symbol (JNJ-N). Instrument Exchange NYSE.Apr 17, 2023 · Johnson & Johnson will report its Q1 results on April 18 before market open. Read what to expect from JNJ stock in terms of earnings and talc litigation. ... (NYSE:JNJ) in January, when I compared ... Find real-time JNJ - Johnson & Johnson stock quotes, company profile, news and forecasts from CNN Business.Sep 28, 2022 11:06PM EDT. We believe Medtronic stock (NYSE: MDT) is currently a better pick than Johnson & Johnson stock (NYSE: JNJ), given its better prospects. Although Medtronic is trading at a ...Apr 17, 2023 · From a stock-performance standpoint, Procter & Gamble has held up better than Johnson & Johnson. While PG stock is roughly flat year-to-date and down 1.5% over the last year, JNJ stock is off 6% ... Open Int (30-Day): The average total open interest for all option contracts (across all expiration dates) for the last 30 days. Johnson & Johnson stocks price quote with latest …
Sundry Photography/iStock Editorial via Getty Images. Johnson & Johnson ( NYSE: JNJ) said Monday that its previously announced offer to shareholders to exchange their shares of JNJ common stock ...Medical technology company Becton, Dickinson & Co (NYSE: BDX) saw shares plummet recently on weaker-than-expected guidance. The company expects revenues of between $20.1 billion and $20.3 billion ...JNJ is currently trading c.34% higher than the estimated price, hence is overvalued. That being said, JNJ is also known for beating analysts’ estimates. In the last 2 years, JNJ beat analysts ...Instagram:https://instagram. what platform to use for forex tradingconventional loan vs usdaforeign exchange trading signalstoday's losers stocks Potentially undervalued companies in the Pharmaceuticals & Biotech industry. Research Johnson & Johnson's (NYSE:JNJ) stock key valuation metrics while comparing it with …Comparison to Industry · Zacks Experts View. More Research. *Price Target & Stock ... NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least ... l n camg gle 63 From a stock-performance standpoint, Procter & Gamble has held up better than Johnson & Johnson. While PG stock is roughly flat year-to-date and down 1.5% over the last year, JNJ stock is off 6% ...Less than two weeks after Johnson & Johnson (NYSE:JNJ) released its Q2 2023 financial report, its investors were shocked that a federal judge had dismissed the company's second attempt to resolve ... is start engine a good investment Morningstar Rating Unlock Stock XNYS Rating as of Nov 30, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating Performance Dividends...Research Pfizer's (NYSE:PFE) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. ... NYSE:JNJ US$381.3b. Price History & Performance. Summary of all time highs, changes and price drops for Pfizer; Historical stock prices; Current Share Price: US$28.91: 52 Week High: